About Tenet Healthcare Corporation
https://www.tenethealth.comTenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
CEO
Saumya Sutaria
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2012-10-11 | Reverse | 1:4 |
| 2002-07-01 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 310
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Guggenheim
Buy
Truist Securities
Buy
UBS
Buy
B of A Securities
Buy
RBC Capital
Outperform
Mizuho
Outperform
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:9.88M
Value:$1.93B
VANGUARD GROUP INC
Shares:9.01M
Value:$1.76B
BLACKROCK, INC.
Shares:8.55M
Value:$1.67B
Summary
Showing Top 3 of 831
About Tenet Healthcare Corporation
https://www.tenethealth.comTenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $5.29B ▲ | $2.2B ▼ | $342M ▲ | 6.47% ▲ | $3.89 ▲ | $1.14B ▲ |
| Q2-2025 | $5.27B ▲ | $3.52B ▲ | $288M ▼ | 5.46% ▼ | $3.16 ▼ | $1.06B ▼ |
| Q1-2025 | $5.22B ▲ | $1.25B ▲ | $406M ▲ | 7.77% ▲ | $4.31 ▲ | $1.18B ▲ |
| Q4-2024 | $5.07B ▼ | $1.23B ▲ | $318M ▼ | 6.27% ▼ | $3.34 ▼ | $1.05B ▼ |
| Q3-2024 | $5.12B | $932M | $472M | 9.22% | $4.93 | $1.33B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $2.98B ▲ | $29.42B ▲ | $20.72B ▲ | $4.01B ▲ |
| Q2-2025 | $2.63B ▼ | $28.7B ▼ | $20.4B ▼ | $3.75B ▼ |
| Q1-2025 | $3B ▼ | $29.24B ▲ | $20.58B ▲ | $4.18B ▲ |
| Q4-2024 | $3.02B ▼ | $28.94B ▼ | $20.39B ▼ | $4.17B ▲ |
| Q3-2024 | $4.09B | $29.37B | $21.3B | $3.83B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $579M ▲ | $1.06B ▲ | $-385M ▼ | $-323M ▲ | $350M ▲ | $778M ▲ |
| Q2-2025 | $522M ▼ | $936M ▲ | $-314M ▼ | $-996M ▼ | $-374M ▼ | $743M ▲ |
| Q1-2025 | $622M ▲ | $815M ▲ | $-187M ▲ | $-648M ▼ | $-20M ▲ | $642M ▲ |
| Q4-2024 | $572M ▼ | $-331M ▼ | $-372M ▼ | $-372M ▲ | $-1.07B ▼ | $-661M ▼ |
| Q3-2024 | $681M | $1.04B | $667M | $-498M | $1.21B | $839M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Ambulatory Care | $3.54Bn ▲ | $1.19Bn ▼ | $1.27Bn ▲ | $1.27Bn ▲ |
 Hospital Operations | $1.27Bn ▲ | $4.03Bn ▲ | $4.00Bn ▼ | $4.01Bn ▲ |
CEO
Saumya Sutaria
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2012-10-11 | Reverse | 1:4 |
| 2002-07-01 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 310
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Guggenheim
Buy
Truist Securities
Buy
UBS
Buy
B of A Securities
Buy
RBC Capital
Outperform
Mizuho
Outperform
Grade Summary
Showing Top 6 of 16
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:9.88M
Value:$1.93B
VANGUARD GROUP INC
Shares:9.01M
Value:$1.76B
BLACKROCK, INC.
Shares:8.55M
Value:$1.67B
Summary
Showing Top 3 of 831